Opana ER

Showing 2 posts of 2 posts found.

Endo withdraws product as FDA secures step in opioid crisis fightback

July 10, 2017
Sales and Marketing Endo pharmaceuticals, FDA, Opana ER

The FDA took the unusual step to ask Endo Pharmaceutical to voluntarily withdraw its opioid painkiller, Opana ER, from the …

Endo says Opana ER supply disruption will be temporary

February 28, 2012
Manufacturing and Production Endo, Novartis, Opana ER

Endo Pharmaceuticals has said that current supply restrictions for its new Opana ER formulation of oxymorphone are likely to be …

The Gateway to Local Adoption Series

Latest content